{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:48:32Z","timestamp":1772200112969,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.bbrc.2023.02.078","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T11:18:21Z","timestamp":1677583101000},"page":"102-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Plasminogen decreases A\u03b242 and Tau deposition, and shows multi-beneficial effects on Alzheimer's disease in mice and humans"],"prefix":"10.1016","volume":"654","author":[{"given":"Chunying","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbrc.2023.02.078_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1039856218762308","article-title":"Alzheimer\u2019s disease: clinical update on epidemiology, pathophysiology and diagnosis","volume":"26","author":"Eratne","year":"2018","journal-title":"Australas. Psychiatr."},{"issue":"7","key":"10.1016\/j.bbrc.2023.02.078_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer\u2019s disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrc.2023.02.078_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.biopha.2018.06.147","article-title":"A\u00a0molecular approach in drug development for Alzheimer\u2019s disease","volume":"106","author":"Agatonovic-Kustrin","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bbrc.2023.02.078_bib4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1134\/S1068162014060028","article-title":"Structure and function of plasminogen\/plasmin system [J]","volume":"40","author":"Aisina","year":"2014","journal-title":"Russ. J. Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2023.02.078_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/abbi.1997.0221","article-title":"Denatured proteins as cofactors for plasminogen activation","volume":"344","author":"Machovich","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbrc.2023.02.078_bib6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/PL00000615","article-title":"The plasminogen activator system: biology and regulation","volume":"56","author":"Irigoyen","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2023.02.078_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1126\/science.1065057","article-title":"Regulation of cell survival by secreted proneurotrophins","volume":"294","author":"Lee","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bbrc.2023.02.078_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","article-title":"GDNF, NGF and BDNF as therapeutic options for neurodegeneration","volume":"138","author":"Allen","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2023.02.078_bib9","unstructured":"Li JN. A Method and Drug for Improving BDNF Level. PCT\/CN2021\/131184."},{"key":"10.1016\/j.bbrc.2023.02.078_bib10","unstructured":"Li JN. A Method and Drug for Improving NGF Level. PCT\/CN2021\/131185."},{"issue":"13","key":"10.1016\/j.bbrc.2023.02.078_bib11","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1097\/00001756-200109170-00042","article-title":"Plasmin cleaves Abeta42 in\u00a0vitro and prevents its aggregation into beta-pleated sheet structures","volume":"12","author":"Exley","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbrc.2023.02.078_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2010.08.025","article-title":"Plasminogen and plasmin in Alzheimer\u2019s disease","volume":"1355","author":"Barker","year":"2010","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.bbrc.2023.02.078_bib13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/npp.2015.279","article-title":"Tissue-plasminogen activator attenuates Alzheimer\u2019s disease-related pathology development in APPswe\/PS1 mice","volume":"41","author":"ElAli","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbrc.2023.02.078_bib14","unstructured":"Li JN. A Method and Drug for Treating Alzheimer's Disease. US17\/914,265."},{"key":"10.1016\/j.bbrc.2023.02.078_bib15","unstructured":"Li JN. A Method and Drug for Treating Amyotrophic Lateral Sclerosis. WO2020\/228681."},{"key":"10.1016\/j.bbrc.2023.02.078_bib16","unstructured":"J.N. Li, Method for prevention or treating diabetic mellitus nerve injury and related diseases, WO\/2017\/101867."},{"key":"10.1016\/j.bbrc.2023.02.078_bib17","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1182\/blood-2012-01-407825","article-title":"Plasminogen is a key proinflammatory regulator that accelerates the healing of acute and diabetic wounds","volume":"119","author":"Shen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2023.02.078_bib18","unstructured":"Li JN. A Method and Drug for Treating Parkinson's Disease. US17\/914,267."},{"issue":"2","key":"10.1016\/j.bbrc.2023.02.078_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cne.24551","article-title":"Sex-biased hippocampal pathology in the 5\u00d7FAD mouse model of Alzheimer\u2019s disease: a multi-omic analysis","volume":"527","author":"Bundy","year":"2019","journal-title":"J.\u00a0Comp. Neurol."},{"issue":"2","key":"10.1016\/j.bbrc.2023.02.078_bib20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1582-4934.2011.01306.x","article-title":"High-molecular weight A\u03b2 oligomers and protofibrils are the predominant A\u03b2 species in the native soluble protein fraction of the AD brain","volume":"16","author":"Upadhaya","year":"2012","journal-title":"J.\u00a0Cell Mol. Med."},{"issue":"7","key":"10.1016\/j.bbrc.2023.02.078_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tins.2020.04.007","article-title":"Resurrecting the mysteries of big Tau","volume":"43","author":"Fischer","year":"2020","journal-title":"Trends Neurosci."},{"issue":"20","key":"10.1016\/j.bbrc.2023.02.078_bib22","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.3390\/ijms20205213","article-title":"Novel peptidomic approach for identification of low and high molecular weight tauopathy peptides following calpain digestion, and primary culture neurotoxic challenges","volume":"20","author":"Yadikar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bbrc.2023.02.078_bib23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.febslet.2008.02.026","article-title":"Activation of pro-BDNF by the pericellular serine protease plasmin","volume":"582","author":"Gray","year":"2008","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bbrc.2023.02.078_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbrc.2023.02.078_bib25","unstructured":"https:\/\/www.nc3rs.org.uk\/3rs-resources\/blood-sampling\/blood-sampling-mouse#:\u223c:text=How%20much%20blood%20does%20a%20mouse%20have%3F%20On,58.5%20ml%2Fkg%20x%200.025%20kg%20%3D%201.46%20ml."},{"issue":"1","key":"10.1016\/j.bbrc.2023.02.078_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.bbrc.2023.02.078_bib27","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.3390\/nu12072036","article-title":"High-fat diet enhances working memory in the Y-maze test in male C57bl\/6J mice with less anxiety in the elevated plus maze test","volume":"12","author":"Yoshizaki","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.bbrc.2023.02.078_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.bbrc.2023.02.078_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/cns.12521","article-title":"Rivastigmine patch in Chinese patients with probable Alzheimer\u2019s disease: a 24-week, randomized, double-blind parallel-group study comparing rivastigmine patch (9.5 mg\/24 h) with capsule (6 mg twice daily)","volume":"22","author":"Zhang","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"10.1016\/j.bbrc.2023.02.078_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035185","article-title":"Efficacy of memantine for agitation in Alzheimer\u2019s dementia: a randomised double-blind placebo controlled trial","volume":"7","author":"Fox","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2023.02.078_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol. Brain"},{"issue":"5","key":"10.1016\/j.bbrc.2023.02.078_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217234","article-title":"Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition","volume":"14","author":"Kaur","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2023.02.078_bib33","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1523\/JNEUROSCI.23-26-08867.2003","article-title":"The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-\u03b2 (A\u03b2) degradation and inhibits A\u03b2-induced neurodegeneration","volume":"23","author":"Melchor","year":"2003","journal-title":"J.\u00a0Neurosci."},{"issue":"6811","key":"10.1016\/j.bbrc.2023.02.078_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/35044100","article-title":"Binding of disease-associated prion protein to plasminogen","volume":"408","author":"Fischer","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2023.02.078_bib35","unstructured":"Jinan, Li, Method for preventing or treating actute thrombosis and chronic thrombosis, WO\/2017\/101866."},{"key":"10.1016\/j.bbrc.2023.02.078_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymeth.2017.08.003","article-title":"Tau-imaging in neurodegeneration","volume":"130","author":"Bischof","year":"2017","journal-title":"Methods"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23002644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23002644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:28:08Z","timestamp":1757766488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23002644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":36,"alternative-id":["S0006291X23002644"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.02.078","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasminogen decreases A\u03b242 and Tau deposition, and shows multi-beneficial effects on Alzheimer's disease in mice and humans","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.02.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}